+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07341282

Evaluating Oral Vancomycin Treatment for Adults with Ulcerative Colitis and Primary Sclerosing Cholangitis A Randomized, Placebo-Controlled Feasibility Study

Led by McMaster University · Updated on 2026-10-09

14

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and effectiveness of oral vancomycin in treating active ulcerative colitis UC in adults who also have primary sclerosing cholangitis PSC, a liver condition. This pilot clinical trial focuses on whether vancomycin can improve UC symptoms measured by the Mayo score after 4 weeks and assesses if the treatment is safe and tolerable for this patient group. The trial is designed as a randomized, placebo-controlled study to provide initial feasibility data for future larger studies. Participants will be randomly assigned to receive either oral vancomycin 250 mg twice daily or identical placebo capsules for 4 weeks in a blinded phase. After this, participants have the option to continue with an additional 4 weeks of open-label vancomycin treatment. The study includes clinic visits at baseline, week 4, and follow-up visits for symptom scoring, endoscopy, blood and stool tests, and safety monitoring. Treatment adherence will be tracked using weekly digital diaries and pill counts. Throughout the study, participants will undergo medical history reviews, infection risk screening, liver disease stability assessments, and safety lab tests at multiple time points. Flexible sigmoidoscopy will be performed at baseline with standardized scoring. Safety labs include blood counts, liver panels, and kidney function tests, with close monitoring for potential ototoxicity. Data collection involves secure storage of clinical and imaging data, with oversight by a safety monitoring committee. The main outcomes include recruitment and retention rates, treatment adherence, and protocol compliance, alongside safety and early signs of clinical response over 12 months.

CONDITIONS

Brief Title

Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

Research Team

N

Neeraj Narula, MD

J

Jaimin Patel

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here